Àڱà ÆòÈ°±Ù Á¾¾ç¿¡¼ MIB-1°ú p53ÀÇ ¹ßÇö ¾ç»ó°ú Áø´ÜÀû À¯¿ë¼º
Expressions and Diagnostic Usefulness of MIB-1 and p53 in Uterine Smooth Muscle Tumors
±è¹ÌÁø, ±è¿ëÁø, À̽ÂÈ£,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¹ÌÁø ( Kim Mi-Jin )
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
±è¿ëÁø ( Kim Yong-Jin )
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
À̽ÂÈ£ ( Lee Seung-Ho )
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
KMID : 0357920010350060524
Abstract
Background: Controversy still remains concerning the criteria for the categorization of uterine smooth muscle tumors by conventional histologic examination. Various ancillary techniques have been used to improve diagnostic accuracy.
Methods: Immunohistochemical study of MIB-1 and p53 was performed on 10 usual leiomyomas (UL), 13 cellular leiomyomas (CL), 5 bizarre leiomyomas (BL), 2 cases of intravenous leiomyomatosis (IL), 5 smooth muscle tumors of uncertain malignant potential (STUMP) and 8 leiomyosarcomas (LMS), to investigate the diagnostic value of MIB-1 and p53 in uterine smooth muscle tumors.
Results: The MIB-1 labelling index was low in ULs and their variants (mean 5.67¡¾5.53), but it was increased in STUMPs (17.67¡¾6.51) and markedly increased in LMSs (35.71¡¾11.35). In ULs and their variants, no immunostaining for p53 was noted except in one case of BL, while 2 (40%) of 5 STUMPs and 3 (38%) of 8 LMSs showed positive reactions for p53. There were significant differences among leiomyoma, STUMP and LMS in the MIB-1 labelling index and p53 expression.
Conclusions: These results suggest that both abnormal expressions of p53 and a high MIB-1 labelling index are frequently associated with leiomyosarcoma. Our data also indicate that the classification system of Kempson and Hendrickson is well correlated with the MIB-1 labelling index.
Å°¿öµå
Uterine neoplasms;Smooth muscle tumor;Protein p53;Ki-67 antigen;Immunohistochemistry
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸